Douglas D. Watts

Array ( [id] => 4149157 [patent_doc_number] => 06063905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Recombinant human IGA-J. chain dimer' [patent_app_type] => 1 [patent_app_number] => 8/779597 [patent_app_country] => US [patent_app_date] => 1997-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 16723 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063905.pdf [firstpage_image] =>[orig_patent_app_number] => 779597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115356 [patent_doc_number] => 06071696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation' [patent_app_type] => 1 [patent_app_number] => 8/774465 [patent_app_country] => US [patent_app_date] => 1996-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10590 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071696.pdf [firstpage_image] =>[orig_patent_app_number] => 774465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994623 [patent_doc_number] => 05892015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Human rhombotin-like protein' [patent_app_type] => 1 [patent_app_number] => 8/777321 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 18331 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892015.pdf [firstpage_image] =>[orig_patent_app_number] => 777321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085087 [patent_doc_number] => 06132978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Method to regulate CD40 signaling' [patent_app_type] => 1 [patent_app_number] => 8/769747 [patent_app_country] => US [patent_app_date] => 1996-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11394 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132978.pdf [firstpage_image] =>[orig_patent_app_number] => 769747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196183 [patent_doc_number] => 06013471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'DNA encoding hK2 variant polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/768859 [patent_app_country] => US [patent_app_date] => 1996-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15539 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013471.pdf [firstpage_image] =>[orig_patent_app_number] => 768859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4188568 [patent_doc_number] => 06093796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Recombinant hK2 polypeptide' [patent_app_type] => 1 [patent_app_number] => 8/767820 [patent_app_country] => US [patent_app_date] => 1996-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15549 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093796.pdf [firstpage_image] =>[orig_patent_app_number] => 767820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098547 [patent_doc_number] => 06051227 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling' [patent_app_type] => 1 [patent_app_number] => 8/760288 [patent_app_country] => US [patent_app_date] => 1996-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 33 [patent_no_of_words] => 20020 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051227.pdf [firstpage_image] =>[orig_patent_app_number] => 760288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407144 [patent_doc_number] => 06309846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Diagnosis and monitoring of colon cancer patients by measurement of NCA 50/90 in blood' [patent_app_type] => 1 [patent_app_number] => 8/755501 [patent_app_country] => US [patent_app_date] => 1996-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 4923 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309846.pdf [firstpage_image] =>[orig_patent_app_number] => 755501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071490 [patent_doc_number] => 05965372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Genetic sequences encoding glucocorticoid dehydrogenases and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/754369 [patent_app_country] => US [patent_app_date] => 1996-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12776 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965372.pdf [firstpage_image] =>[orig_patent_app_number] => 754369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4033974 [patent_doc_number] => 05856182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Monoclonal antibodies specific for the PSA-ACT complex' [patent_app_type] => 1 [patent_app_number] => 8/749525 [patent_app_country] => US [patent_app_date] => 1996-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 6293 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856182.pdf [firstpage_image] =>[orig_patent_app_number] => 749525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915030 [patent_doc_number] => 06001962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Modified Fas ligands' [patent_app_type] => 1 [patent_app_number] => 8/751512 [patent_app_country] => US [patent_app_date] => 1996-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 13130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001962.pdf [firstpage_image] =>[orig_patent_app_number] => 751512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946699 [patent_doc_number] => 05990294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Nucleotide and amino acid sequences of C4-2, a tumor suppressor gene, and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/744905 [patent_app_country] => US [patent_app_date] => 1996-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 22 [patent_no_of_words] => 25773 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990294.pdf [firstpage_image] =>[orig_patent_app_number] => 744905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807508 [patent_doc_number] => 05854205 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Therapeutic antiangiogenic compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/740168 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 16907 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854205.pdf [firstpage_image] =>[orig_patent_app_number] => 740168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4116112 [patent_doc_number] => 06071741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Doc tumor suppressor protein and gene' [patent_app_type] => 1 [patent_app_number] => 8/728839 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 13175 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071741.pdf [firstpage_image] =>[orig_patent_app_number] => 728839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356176 [patent_doc_number] => 06190901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Chicken interleukin-15 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/729004 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5617 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190901.pdf [firstpage_image] =>[orig_patent_app_number] => 729004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996930 [patent_doc_number] => 05922676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods of inhibiting cancer by using superfibronectin' [patent_app_type] => 1 [patent_app_number] => 8/717169 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 18394 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922676.pdf [firstpage_image] =>[orig_patent_app_number] => 717169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933342 [patent_doc_number] => 05939387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Method of treating insulin resistance' [patent_app_type] => 1 [patent_app_number] => 8/708620 [patent_app_country] => US [patent_app_date] => 1996-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5179 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939387.pdf [firstpage_image] =>[orig_patent_app_number] => 708620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3817233 [patent_doc_number] => 05789550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'TRAF inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/700749 [patent_app_country] => US [patent_app_date] => 1996-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 14129 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789550.pdf [firstpage_image] =>[orig_patent_app_number] => 700749 [rel_patent_id] =>[rel_patent_doc_number] =>)